135 related articles for article (PubMed ID: 11136779)
41. Comparison of antigenemia assay and semiquantitative polymerase chain reaction test for monitoring active cytomegalovirus infection in allogeneic hematopoietic cell transplant recipients.
Pajand O; Ziyaeyan M; Mousavi S; Fatolahzadeh B; Hojabri Z; Bahador A; Abdossamadi Z
Exp Clin Transplant; 2008 Jun; 6(2):149-54. PubMed ID: 18816243
[TBL] [Abstract][Full Text] [Related]
42. Quantitative analysis of HCMV DNA load in whole blood of renal transplant patients using real-time PCR assay.
Gouarin S; Vabret A; Gault E; Petitjean J; Regeasse A; Hurault de Ligny B; Freymuth F
J Clin Virol; 2004 Mar; 29(3):194-201. PubMed ID: 14962789
[TBL] [Abstract][Full Text] [Related]
43. Prospective comparison of PCR-based vs late mRNA-based preemptive antiviral therapy for HCMV infection in patients after allo-SCT.
Hebart H; Lengerke C; Ljungman P; Paya CV; Klingebiel T; Loeffler J; Pfaffenrath S; Lewensohn-Fuchs I; Barkholt L; Tomiuk J; Meisner C; Lunenberg J; Top B; Razonable RR; Patel R; Litzow MR; Jahn G; Einsele H
Bone Marrow Transplant; 2011 Mar; 46(3):408-15. PubMed ID: 20581879
[TBL] [Abstract][Full Text] [Related]
44. Comparison of cytomegalovirus viral load measure by real-time PCR with pp65 antigenemia for the diagnosis of cytomegalovirus disease in solid organ transplant patients.
Hernando S; Folgueira L; Lumbreras C; San Juan R; Maldonado S; Prieto C; Babiano MJ; Delgado J; Andres A; Moreno E; Aguado JM; Otero JR
Transplant Proc; 2005 Nov; 37(9):4094-6. PubMed ID: 16386635
[TBL] [Abstract][Full Text] [Related]
45. In situ detection of DNA and mRNA of human cytomegalovirus to distinguish different forms of viral infection in leukocytes.
Zawilinska B; Bulek K; Kopec J; Kosz-Vnenchak M
Acta Biochim Pol; 2006; 53(3):457-61. PubMed ID: 17019440
[TBL] [Abstract][Full Text] [Related]
46. Diagnosing cytomegalovirus disease in CMV seropositive renal allograft recipients: a comparison between the detection of CMV DNAemia by polymerase chain reaction and antigenemia by CMV pp65 assay.
Lo CY; Ho KN; Yuen KY; Lui SL; Li FK; Chan TM; Lo WK; Cheng IK
Clin Transplant; 1997 Aug; 11(4):286-93. PubMed ID: 9267717
[TBL] [Abstract][Full Text] [Related]
47. Comparison of two commercially available pp65 antigenemia tests and COBAS Amplicor CMV Monitor for early detection and quantification of episodes of human CMV-viremia in transplant recipients.
May G; Kuhn JE; Eing BR
Intervirology; 2006; 49(5):261-5. PubMed ID: 16714854
[TBL] [Abstract][Full Text] [Related]
48. Monitoring for cytomegalovirus infection in organ transplant recipients: analysis of pp65 antigen, DNA and late mRNA in peripheral blood leukocytes.
Gaeta A; Nazzari C; Angeletti S; Lazzarini M; Mazzei E; Mancini C
J Med Virol; 1997 Nov; 53(3):189-95. PubMed ID: 9365881
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of cytomegalovirus DNAaemia versus pp65-antigenaemia cutoff for guiding preemptive therapy in transplant recipients: a randomized study.
Gerna G; Baldanti F; Torsellini M; Minoli L; Viganò M; Oggionnis T; Rampino T; Castiglioni B; Goglio A; Colledan M; Mammana C; Nozza F; Daniele L;
Antivir Ther; 2007; 12(1):63-72. PubMed ID: 17503749
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of human cytomegalovirus gene expression in thoracic organ transplant recipients using nucleic acid sequence-based amplification.
Oldenburg N; Lam KM; Khan MA; Top B; Tacken NM; McKie A; Mikhail GW; Middeldorp JM; Wright A; Banner NR; Yacoub M
Transplantation; 2000 Oct; 70(8):1209-15. PubMed ID: 11063343
[TBL] [Abstract][Full Text] [Related]
51. Qualitative plasma PCR assay (AMPLICOR CMV test) versus pp65 antigenemia assay for monitoring cytomegalovirus viremia and guiding preemptive ganciclovir therapy in allogeneic stem cell transplantation.
Solano C; Muñoz I; Gutiérrez A; Farga A; Prósper F; García-Conde J; Navarro D; Gimeno C
J Clin Microbiol; 2001 Nov; 39(11):3938-41. PubMed ID: 11682510
[TBL] [Abstract][Full Text] [Related]
52. Expression of the late cytomegalovirus (CMV) pp150 transcript in leukocytes of AIDS patients is associated with a high viral DNA load in leukocytes and presence of CMV DNA in plasma.
Boivin G; Handfield J; Toma E; Lalonde R; Bergeron MG
J Infect Dis; 1999 May; 179(5):1101-7. PubMed ID: 10191210
[TBL] [Abstract][Full Text] [Related]
53. Analysis of cytomegalovirus (CMV) viremia using the pp65 antigenemia assay, the amplicor CMV test, and a semi-quantitative polymerase chain reaction test after allogeneic marrow transplantation.
Ksouri H; Eljed H; Greco A; Lakhal A; Torjman L; Abdelkefi A; Ben Othmen T; Ladeb S; Slim A; Zouari B; Abdeladhim A; Ben Hassen A
Transpl Infect Dis; 2007 Mar; 9(1):16-21. PubMed ID: 17313466
[TBL] [Abstract][Full Text] [Related]
54. In situ RT-PCR can distinguish between productive and latent cytomegalovirus infection in the blood cells of bone marrow transplant recipients.
Zawilinska B; Bulek K; Kopec J; Daszkiewicz E; Rojek-Zakrzewska D; Kosz-Vnenchak M
Acta Virol; 2006; 50(1):67-70. PubMed ID: 16599188
[TBL] [Abstract][Full Text] [Related]
55. Monitoring low cytomegalovirus viremia in transplanted patients by a real-time PCR on plasma.
Schvoerer E; Henriot S; Zachary P; Freitag R; Fuchs A; Fritsch S; Risch S; Meyer N; Caillard S; Lioure B; Stoll-Keller F
J Med Virol; 2005 May; 76(1):76-81. PubMed ID: 15778970
[TBL] [Abstract][Full Text] [Related]
56. Prospective evaluation of the clinical utility of different methods for the detection of human cytomegalovirus disease after liver transplantation.
Seehofer D; Meisel H; Rayes N; Stein A; Langrehr JM; Settmacher U; Neuhaus P
Am J Transplant; 2004 Aug; 4(8):1331-7. PubMed ID: 15268736
[TBL] [Abstract][Full Text] [Related]
57. Lack of prompt expansion of cytomegalovirus pp65 and IE-1-specific IFNgamma CD8+ and CD4+ T cells is associated with rising levels of pp65 antigenemia and DNAemia during pre-emptive therapy in allogeneic hematopoietic stem cell transplant recipients.
Tormo N; Solano C; Benet I; Clari MA; Nieto J; de la Cámara R; López J; López-Aldeguer N; Hernández-Boluda JC; Remigia MJ; Garcia-Noblejas A; Gimeno C; Navarro D
Bone Marrow Transplant; 2010 Mar; 45(3):543-9. PubMed ID: 19617905
[TBL] [Abstract][Full Text] [Related]
58. Comparison of a UL111a real-time PCR and pp65 antigenemia for the detection of cytomegalovirus.
Beckmann C; Dumoulin A; Rinaldo CH; Hirsch HH
J Med Virol; 2011 Dec; 83(12):2143-50. PubMed ID: 22012722
[TBL] [Abstract][Full Text] [Related]
59. Monitoring of human cytomegalovirus infection in immunosuppressed patients using real-time PCR on whole blood.
Deback C; Fillet AM; Dhedin N; Barrou B; Varnous S; Najioullah F; Bricaire F; Agut H
J Clin Virol; 2007 Nov; 40(3):173-9. PubMed ID: 17904901
[TBL] [Abstract][Full Text] [Related]
60. Humoral immune response against human cytomegalovirus (HCMV)-specific proteins after HCMV infection in lung transplantation as detected with recombinant and naturally occurring proteins.
van Zanten J; Harmsen MC; van der Giessen M; van der Bij W; Prop J; de Leij L; The TH
Clin Diagn Lab Immunol; 1995 Mar; 2(2):214-8. PubMed ID: 7535179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
